Complete Occlusion of Coilable Aneurysms
Status: | Completed |
---|---|
Conditions: | Cardiology, Neurology |
Therapuetic Areas: | Cardiology / Vascular Diseases, Neurology |
Healthy: | No |
Age Range: | 21 - 75 |
Updated: | 4/21/2016 |
Start Date: | October 2008 |
End Date: | April 2015 |
To compare the safety and effectiveness of Pipeline Embolization Device to coil embolization
for the treatment of coilable wide-necked intracranial aneurysms
for the treatment of coilable wide-necked intracranial aneurysms
Inclusion Criteria:
- Age 21 to 75 years, inclusive
- Patient has a single target IA that:
1. is located in the following regions of the internal carotid artery: i.
Paraophthalmic (including paraclinoid, ophthalmic and hypophyseal segments) ii.
Cavernous iii. Petrous
2. is saccular
3. has a parent vessel with diameter 2.5-5.0 mm
- If target IA has a neck >4 mm, at least 2 of 3 members of an independent expert
committee (IEC) have confirmed that coil embolization with optional adjunctive
techniques** has a very high likelihood of procedural success (i.e., coil placement
and retention)
- Subject has provided written informed consent using the IRB-approved consent form
- Subject has the necessary mental capacity to participate and is willing and able to
comply with protocol requirements
- ** Adjunctive techniques include intravascular balloons ["balloon remodeling"],
3D coils, dual catheter techniques.
Exclusion Criteria:
- Target IA has BOTH neck >4 mm AND size (maximum fundus diameter) >10 mm
- More than one IA requires treatment in the next 6 months
- Subarachnoid hemorrhage in the past 60 days
- Any intracranial hemorrhage in the last 42 days
- Major surgery in the last 42 days
- Coils in place in the target IA
- Unstable neurologic deficit (i.e., any worsening of clinical condition in the last 30
days)
- Known irreversible bleeding disorder
- Platelet count < 100 x 103 cells/mm3 or known platelet dysfunction
- Inability to tolerate, documented evidence of adverse reaction or contraindication to
study medications
- Prior stent placement at target site
- Contraindication to CT scan AND MRI
- Known allergy to contrast used in angiography that cannot be medically controlled
- Known severe allergy to platinum or cobalt/chromium alloys
- Relative contraindication to angiography (e.g., serum creatinine > 2.5 mg/dL)
- Woman of child-bearing potential who cannot provide a negative pregnancy test
- Evidence of active infection at the time of treatment
- Other known conditions of the heart, blood, brain or intracranial vessels that carry
a high risk of neurologic events (e.g., severe heart failure, atrial fibrillation,
known carotid stenosis)
- Current use of cocaine or other illicit substance
- Any comorbid disease or condition expected to compromise survival or ability to
complete follow-up assessments to 180 days
- Extracranial stenosis greater than 50% in the carotid artery
- Intracranial stenosis greater than 50% in the treated vessel
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials